2011 G
Pill imprint 2011 G has been identified as Orphenadrine citrate 100 mg.
Orphenadrine is used in the treatment of muscle spasm; migraine and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy.
Orphenadrine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Orphenadrine citrate Images
- Imprint:
-
2011
G - Strength:
- 100 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- ethylcellulose
povidone
lactose monohydrate
magnesium stearate
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
- National Drug Code (NDC):
- 00115-2011
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66267-0158 | Nucare Pharmaceuticals Inc (repackager) |
| 55289-0877 | PDRX Pharmaceuticals Inc (repackager) |
| 68387-0575 | Keltman Pharmaceuticals Inc (repackager) |
| 21695-0099 | Rebel Distributors Corp (repackager) |
| 23490-6039 | Palmetto State Pharmaceuticals Inc (repackager) |
| 67544-0589 | Prepak Systems Inc (repackager) |
| 66336-0554 | Dispensing Solutions Inc. (repackager) |
| 18837-0117 | Innoviant Pharmacy Inc (repackager) |
| 58016-0248 | Southwood Pharmaceuticals Inc (repackager) |
| 16590-0177 | Stat RX USA LLC (repackager) |
| 49999-0046 | Lake Erie Medical and Surgical Supply (repackager) |
| 63874-0531 | Altura Pharmaceuticals Inc (repackager) |
| 55887-0670 | Diversified Healthcare Services Inc (repackager) |
| 33261-0088 | Aidarex Pharmacuticals LLC (repackager) |
Note: Inactive ingredients may vary.
More Orphenadrine Citrate resources
- Orphenadrine (Wolters Kluwer)
- Orphenadrine Extended-Release Tablets (Wolters Kluwer)
- orphenadrine (Cerner Multum)
- orphenadrine (Micromedex) - Includes Dosage Information
- orphenadrine Injection (Micromedex) - Includes Dosage Information
- Orphenadrine Citrate (AHFS DI)
- Orphenadrine Extended Release Tablets (FDA)
- Orphenadrine Injection (FDA)
- Orphenadrine Citrate (Wolters Kluwer)


